They found that 12% of considered MM patients carry genomic mutations not correlated to asbestos exposure, and other 13 genes (apart from BAP1) have been identified as predisposing factors linked to MM development, including TMEM127, CHEK2, MRE11A, VHL, WT1, and SDHA (22). Here, CHEK2 is linked to Miyoshi myopathy.